| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer. | Clin Cancer Res | 2007 | 5.36 |
| 2 | A phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancer. | Cancer Chemother Pharmacol | 2010 | 1.32 |
| 3 | Assessing quality of life in the treatment of patients with age-related macular degeneration: clinical research findings and recommendations for clinical practice. | Clin Ophthalmol | 2013 | 0.97 |
| 4 | Hepatitis C virus in Asia: utility values based on the Short Form-36 questionnaire. | Expert Rev Pharmacoecon Outcomes Res | 2012 | 0.75 |